Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Graeme Sutherland launches The Long Goodbye podcast
9+ hour, 52+ min ago (216+ words) A new podcast is launching to provide support and understanding for families affected by Alzheimer’s disease and dementia. Graeme Sutherland, a media influencer and content creator, is launching The Long Goodbye, a series inspired by his own family’s experience after…...
Kota medical student receives ACPs Researcher of the Year Award
9+ hour, 23+ min ago (14+ words) ...
BBC News - New Treatment Gives Hope to People with Ovarian Cancer
1+ day, 38+ min ago (59+ words) The former nurse, who was told her stage four ovarian cancer was inoperable, is now cancer-free, thanks to a pioneering new treatment developed in Southampton. New Treatment Gives Hope to People with Ovarian Cancer The former nurse, who was told…...
Hematology & Oncology News - Healio
5+ hour, 3+ min ago (275+ words) HemOnc Today - Find hematology and oncology news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles from the #1 online source for hematologists and oncologists, HemOnc Today. Veterans with melanoma may face higher risk for Parkinsonâs…...
Runners raise money for children with cancer on East Bay Bike Path
13+ hour, 41+ min ago (33+ words) Yahoo Hundreds of runners took to the East Bay Bike Path on Saturday for the Mark Palumbo Memorial University Orthopedics 5K....
Enhertu® Demonstrated a Median Progression-Free Survival of 14.3 Months as First-Line Therapy in Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial
14+ hour, 1+ min ago (848+ words) Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). In the primary endpoint analysis, Enhertu monotherapy significantly reduced…...
Lancashire cancer clinicians take on 140-mile charity bike ride
7+ hour, 54+ min ago (639+ words) Cancer clinicians from Lancashire Teaching Hospitals are set to cycle more than 140 miles across Lancashire and Cumbria to raise funds for charity and promote a programme helping patients prepare for treatment. About 20 members of staff are due to set off…...
New palliative care unit for children to be set up in memory of Gourock campaigner
12+ hour, 8+ min ago (694+ words) A GROUND-BREAKING new unit to care for children with terminal illnesses is to be set up in the name of incredible Gourock campaigner Molly Cuddihy a year after her death. Molly's Suite is a palliative care hub to be created…...
Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial
12+ hour, 16+ min ago (338+ words) Results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, South Korea (abstract #PL03.08). In the primary endpoint of PFS, Enhertu monotherapy…...
Holistic palliative care is in the conversations of dying well
15+ hour, 20+ min ago (1807+ words) Vandersman didn’t come to palliative care from arm’s length. It was her top pick. “Palliative care was my first choice in my RN graduate program, other staff were astonished, ‘you could have done theatre or ICU?’” “In the culture I…...